Ethnicity and the Diagnosis of Affective Illness

种族与情感疾病的诊断

基本信息

批准号：
7269364
负责人：
IRA Marc LESSER
金额：
$ 23.53万
依托单位：
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-07-15 至 2009-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7269364
关键词：
Address Affect Affective Affective Symptoms African American Agreement Antipsychotic Agents Clinical Clinical Research Collaborations Condition Consensus Coupled Developed Countries Developing Countries Diagnosis Diagnostic Ethnic Origin Ethnic group Exhibits Failure Goals High Prevalence Humanities Interview Latino Major Depressive Disorder Medical Mental disorders Mind Minority Mood Disorders Moods Patients Pharmaceutical Preparations Pharmacotherapy Prevalence Principal Investigator Psychiatric therapeutic procedure Public Health Range Rate Records Recruitment Activity Relative (related person)Reporting Research Research Personnel Risk Schizophrenia Severities Site Structure Symptoms Testing United States Work care delivery clinical Diagnosis disability dosage ethnic minority population men prescription document prescription procedure programs sex

项目摘要

DESCRIPTION (provided by applicant): Mood disorders are among the most common and debilitating conditions affecting humanity. Correctly identifying and treating mood disorders is critical in order to address this serious public health problem. However, African-Americans with mood disorders are significantly more likely than white patients to be misdiagnosed with schizophrenia. Consequently, African-Americans are at increased risk for receiving inadequate treatment. Failure to correctly identify African-Americans with these conditions contributes to disparities in medical care delivery between ethnic minority and majority patients. However, it is not known why African-Americans with mood disorders are more likely than whites to be misdiagnosed with schizophrenia. Previous investigators suggested that misdiagnoses of schizophrenic disorders appeared to occur because clinicians failed to elicit affective symptoms from African-Americans with mood disorders. Moreover, when mood and psychotic symptoms were both identified, clinicians appeared to minimize the affective symptoms in African-American men. These findings suggest the hypothesis that African-Americans with severe mood disorders are more likely than whites to be misdiagnosed with schizophrenia because clinicians over-emphasize psychotic symptoms at the expense of mood symptoms in the former. Consistent with this hypothesis, African- Americans are more likely to receive excess antipsychotics. Previous studies typically contrasted only African- American and white patients, so it is unknown whether this problem of misdiagnosis is unique to African-Americans or also occurs in other U.S. minorities. Although some studies reported that mood disorders were also commonly misdiagnosed as schizophrenia in Latinos, other work disagreed. Because there are few studies of these issues in Latinos, it is difficult to identify associations among diagnosis, treatment and ethnicity in this patient group. With these considerations in mind, we propose a large, regionally diverse, six-site collaborative R01 study to examine the effects of ethnicity on clinical diagnosis and treatment assignment in African-American, Latino and white patients with mood disorders. The primary objective is to test the hypothesis that clinicians over-emphasize psychotic symptoms at the expense of affective symptoms in African-Americans, leading to an excess of clinical diagnoses of schizophrenia relative to other ethnic groups. A second objective is to test the hypothesis that over-emphasis of psychotic symptoms also contributes to increased antipsychotic use in African-Americans. The final objective is to determine whether Latinos are at risk for similar problems in diagnostic assessments and treatment assignment.

描述（由申请人提供）：情绪障碍是影响人类的最常见和最令人衰弱的疾病之一。正确识别和治疗情绪障碍对于解决这一严重的公共卫生问题至关重要。然而，患有情绪障碍的非裔美国人比白人患者更容易被误诊为精神分裂症。因此，非裔美国人接受不充分治疗的风险增加。未能正确识别患有这些疾病的非裔美国人会导致少数族裔和多数患者之间的医疗服务提供差异。然而，目前尚不清楚为什么患有情绪障碍的非裔美国人比白人更容易被误诊为精神分裂症。之前的研究人员认为，精神分裂症的误诊似乎是因为临床医生未能从患有情绪障碍的非裔美国人身上引出情感症状。此外，当情绪和精神病症状同时被发现时，临床医生似乎会尽量减少非裔美国男性的情感症状。这些发现表明，患有严重情绪障碍的非裔美国人比白人更有可能被误诊为精神分裂症，因为临床医生过分强调精神病症状，而忽视了前者的情绪症状。与这一假设一致，非裔美国人更有可能服用过量的抗精神病药物。以前的研究通常只对比非裔美国人和白人患者，因此尚不清楚这种误诊问题是否是非裔美国人所独有的，还是也发生在美国其他少数族裔中。尽管一些研究报告称，拉丁美洲人的情绪障碍也常被误诊为精神分裂症，但其他研究则不同意这一观点。由于对拉丁美洲人这些问题的研究很少，因此很难确定该患者群体的诊断、治疗和种族之间的关联。考虑到这些因素，我们提出了一项大型、区域多样化、六中心协作 R01 研究，以研究种族对非裔美国人、拉丁裔和白人情绪障碍患者的临床诊断和治疗分配的影响。主要目的是检验这样的假设：临床医生过分强调非裔美国人的精神病症状，而忽视了情感症状，导致相对于其他种族群体而言，精神分裂症的临床诊断过多。第二个目标是检验这样的假设：过度强调精神病症状也会导致非裔美国人抗精神病药物的使用增加。最终目标是确定拉丁裔在诊断评估和治疗分配中是否面临类似问题的风险。